Discontinued — last reported Q1 '17
Johnson & Johnson Investment Proceeds decreased by 33.5% to $489.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.9%, from $466.00M to $489.00M.
An increase indicates the company is liquidating its investment portfolio, potentially to fund large capital projects, acquisitions, or dividends.
The cash received from the sale or maturity of investment securities, including government bonds and corporate debt. Thi...
This metric is often analyzed alongside 'Purchases of Investments' to determine the net movement in a company's 'cash pile'.
cf_proceeds_from_investments| Q2 '21 | Q2 '22 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.23B | $6.30B | $7.77B | $979.00M | $727.00M | $466.00M | $290.00M | $218.00M | $735.00M | $489.00M |
| QoQ Change | — | +20.4% | +23.2% | -87.4% | -25.7% | -35.9% | -37.8% | -24.8% | +237.2% | -33.5% |
| YoY Change | — | +20.4% | +23.2% | — | -90.6% | — | — | -77.7% | +1.1% | +4.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.